Chris Cannon, MD, Talks Trends in Cardiovascular Risk Prevention
By DocWire News Editors - Last Updated: October 26, 2018DocWire News talks with Chris Cannon, MD, cardiologist and professor of medicine at Harvard Medical School and a senior physician at Brigham and Women’s Hospital, about trends in medications for cardiovascular risk prevention. Topics touched on include lipid-lowering drugs, diabetes drugs and more.
Advertisement
Advertisement
Related Posts
The newly approve products include four new sizes.
PEGS were developed from whole-blood DNA methylation samples for items such as blood pressure, BMI, and C-reactive protein.
Food insecurity is linked with an increased risk of developing heart disease.
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
After one year of therapeutic intervention, less oxidation and aggregation were detected in lipoproteins.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.